Literature DB >> 31527816

Newly diagnosed myeloma patients with low-burden disease may benefit from tandem autologous stem cell transplantation: results of long-term follow-up.

Noam Benyamini1, Noa Lavi2,3, Tsila Zuckerman2,3, Ariel Aviv4, Jacob M Rowe2,3,5, Tamar Katz2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31527816     DOI： 10.1038/s41409-019-0671-5

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

Review 1.  First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies.

Authors:  Frauke Naumann-Winter; Alexander Greb; Peter Borchmann; Julia Bohlius; Andreas Engert; Roland Schnell
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.